New Blood Tests Improve Early Detection of Pancreatic Cancer
New blood tests like the Grail Galleri offer hope for early detection of pancreatic cancer, which is crucial as most cases are diagnosed late with poor survival rates. Early detection can significantly improve treatment outcomes, but current screening options are limited, and the disease remains deadly, especially in Ohio where incidence and mortality rates are high. Researchers emphasize the importance of clinical trials and awareness efforts to improve prognosis and develop better therapies.
